In such a model, addition of T0901317 restores insulin-stimulated glucose up-take, fatty acid synthase expression and counteracts metabolic disorder by decreasing secretion of the pro-inflammatory cytokine IL6 (67). Here, IL6 is linked to metabolic disease.